Understanding the CaR- mediated signaling pathway that is involved in prostate cancer cell migration could lead to new targets for drug development and therapeutic strategies for AR- deficient prostate cancer and recurrence of prostate cancer after ADT. Here, AR is linked to prostate cancer.